Instem Plc

  • Market Cap: N/A
  • Industry: Information Technology Services
  • ISIN: GB00B3TQCK30
GBP
8.30
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

3.8 k

Shareholding (Dec 2021)

FII

33.46%

Held by 26 FIIs

DII

0

Held by 1 DIIs

Promoter

0.01%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Information Technology Services

stock-summary
Market cap

GBP 200 Million ()

stock-summary
P/E

43.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.13

stock-summary
Return on Equity

8.59%

stock-summary
Price to Book

3.65

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
37.76%
0%
37.76%
6 Months
33.87%
0%
33.87%
1 Year
22.06%
0%
22.06%
2 Years
3.75%
0%
3.75%
3 Years
90.8%
0%
90.8%
4 Years
123.12%
0%
123.12%
5 Years
184.25%
0%
184.25%

Instem Plc for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
22.78%
EBIT Growth (5y)
23.74%
EBIT to Interest (avg)
4.27
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.13
Sales to Capital Employed (avg)
1.16
Tax Ratio
3.15%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
22.78%
ROE (avg)
11.23%
Valuation key factors
Factor
Value
P/E Ratio
43
Industry P/E
Price to Book Value
3.65
EV to EBIT
31.49
EV to EBITDA
18.89
EV to Capital Employed
4.05
EV to Sales
3.16
PEG Ratio
0.70
Dividend Yield
NA
ROCE (Latest)
12.86%
ROE (Latest)
8.59%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2021stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Domestic Funds

Held in 1 Schemes (0.32%)

Foreign Institutions

Held by 26 Foreign Institutions (33.46%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Instem Plc"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'22",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2022 is 28.04% vs 63.12% in Dec 2021",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2022 is 176.47% vs -26.09% in Dec 2021",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'22",
        "Dec'21",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "58.90",
          "val2": "46.00",
          "chgp": "28.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "10.90",
          "val2": "8.10",
          "chgp": "34.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.30",
          "val2": "0.20",
          "chgp": "50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.70",
          "val2": "-1.20",
          "chgp": "-41.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4.70",
          "val2": "1.70",
          "chgp": "176.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "110.50%",
          "val2": "95.80%",
          "chgp": "1.47%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Dec'22stock-summary
Dec'22
Dec'21
Change(%)
Net Sales
58.90
46.00
28.04%
Operating Profit (PBDIT) excl Other Income
10.90
8.10
34.57%
Interest
0.30
0.20
50.00%
Exceptional Items
-1.70
-1.20
-41.67%
Consolidate Net Profit
4.70
1.70
176.47%
Operating Profit Margin (Excl OI)
110.50%
95.80%
1.47%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2022 is 28.04% vs 63.12% in Dec 2021

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2022 is 176.47% vs -26.09% in Dec 2021

stock-summaryCompany CV
About Instem Plc stock-summary
stock-summary
Instem Plc
Information Technology Services
Instem plc is a supplier of information technology (IT) applications to the early development healthcare market delivering solutions for data collection, management and analysis across the research and development continuum. The Company is engaged in Global Life Sciences operations. Its lead product suite, Provantis, is an application in the Early Development Safety Assessment (EDSA) market. The Provantis solution incorporates a suite of modules required for managing and recording EDSA studies, from receipt of the compound through to the automated assembly of statistical analyses and final reports. Its software allows scientific staff to collect, analyze and share data across the organization and externally. It also offers ALPHADAS, an early phase clinical software solution. The Company offers Centrus suite, which provides pre-built applications, as well as the ability to utilize a range of business intelligence and analysis tools.
Company Coordinates stock-summary
Company Details
Diamond Way, Stone Business Park , STONE None : ST15 0SD
stock-summary
Tel: 44 1785 825600
stock-summary
Registrar Details